- Home
- MFH vs EBS Comparison
MFH vs EBS Comparison
Compare MFH & EBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFH
- EBS
- Stock Information
- Founded
- MFH 2011
- EBS 1998
- Country
- MFH United States
- EBS United States
- Employees
- MFH N/A
- EBS N/A
- Industry
- MFH Finance: Consumer Services
- EBS Biotechnology: Pharmaceutical Preparations
- Sector
- MFH Finance
- EBS Health Care
- Exchange
- MFH Nasdaq
- EBS Nasdaq
- Market Cap
- MFH 372.5M
- EBS 393.9M
- IPO Year
- MFH N/A
- EBS 2006
- Fundamental
- Price
- MFH $6.08
- EBS $5.65
- Analyst Decision
- MFH
- EBS Strong Buy
- Analyst Count
- MFH 0
- EBS 3
- Target Price
- MFH N/A
- EBS $14.33
- AVG Volume (30 Days)
- MFH 92.0K
- EBS 1.1M
- Earning Date
- MFH 05-16-2025
- EBS 05-07-2025
- Dividend Yield
- MFH N/A
- EBS N/A
- EPS Growth
- MFH N/A
- EBS N/A
- EPS
- MFH N/A
- EBS N/A
- Revenue
- MFH $1,007,430.00
- EBS $965,400,000.00
- Revenue This Year
- MFH N/A
- EBS N/A
- Revenue Next Year
- MFH N/A
- EBS $19.88
- P/E Ratio
- MFH N/A
- EBS N/A
- Revenue Growth
- MFH 125.92
- EBS N/A
- 52 Week Low
- MFH $1.03
- EBS $4.02
- 52 Week High
- MFH $8.86
- EBS $15.10
- Technical
- Relative Strength Index (RSI)
- MFH 47.24
- EBS 55.12
- Support Level
- MFH $5.30
- EBS $4.71
- Resistance Level
- MFH $7.90
- EBS $6.70
- Average True Range (ATR)
- MFH 0.81
- EBS 0.43
- MACD
- MFH -0.08
- EBS 0.13
- Stochastic Oscillator
- MFH 30.00
- EBS 53.33
About MFH Mercurity Fintech Holding Inc.
Mercurity Fintech Holding Inc is a New York-based digital fintech leader providing access to the rapidly growing AI-powered infrastructure, blockchain, and digital assets sectors. Its three core business lines include: 1. Blockchain and digital asset solutions. 2. AI and HPC infrastructure, specializing in developing liquid cooling solutions for AI data centers. 3. Comprehensive financial services.
About EBS Emergent Biosolutions Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.